Vaxcyte, Inc.

NASDAQ:PCVX

96.63 (USD) • At close November 13, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 00014.4460000000000000000000
Kosten van de omzet 4.5033.4783.0912.9482.482.4012.3422.32.3542.1642.3691.2060.8460.8680.52700000000
Brutowinst -4.503-3.478-3.09111.498-2.48-2.401-2.342-2.3-2.354-2.164-2.369-1.206-0.846-0.868-0.52700000000
Brutowinstmarge 0000.7960000000000000000000
Onderzoek- en ontwikkelingskosten 116.936131.50794.587104.1597.42172.69158.0851.62647.67938.46931.67823.07420.42817.65117.25814.66116.4118.17824.31513.3829.639.96812.628
Algemene en administratieve kosten 22.98821.47419.88517.52615.60514.45613.11211.95210.8989.4177.5436.7726.5236.0795.8854.7924.8983.0463.2812.4572.512.2641.316
Verkoop- en marketingkosten 0-3.4780-2.9480000000000000000000
Verkoop-, algemene en administratieve kosten 22.98817.99619.88514.57815.60514.45613.11211.95210.8989.4177.5436.7726.5236.0795.8854.7924.8983.0463.2812.4572.512.2641.316
Overige kosten 0-0.394075.65400-0.654-0.925-0.157-0.69-0.16-0.908-0.299-0.378000000.6650.8441.450.226
Bedrijfskosten 139.924149.503114.346118.728113.02684.68370.53862.65358.4247.19639.06128.93826.65223.35223.14319.12720.52120.18827.26715.65612.08612.23213.944
Bedrijfsresultaat -139.924-152.981-114.472-121.676-113.026-87.147-71.192-86.573-58.577-47.886-39.221-29.846-26.951-23.73-23.143-19.453-21.308-21.224-27.596-15.839-12.14-12.232-13.944
Bedrijfsresultaat ratio 000-8.4230000000000000000000
Totaal overige inkomsten en kosten netto 36.824.27819.45215.87520.36218.80810.738.5230.66-0.6460.2351.2830.3360.0511.923-1.2840.290.9040.4541.2180.8231.5670.273
Inkomen voor belasting -103.124-128.703-95.02-180.801-92.664-68.339-60.462-78.05-57.917-48.532-38.986-28.563-26.615-23.679-21.22-20.737-21.018-20.32-27.142-14.621-11.317-10.665-13.671
Inkomen voor belasting ratio 000-12.5160000000000000000000
Belastingkosten -4.5030-19.32614.581-2.482.279-12.10115.397-0.660.646-0.23500.010.0070-0.332-0.33400.0070.6720.8531.4610.239
Nettowinst -103.124-128.703-95.02-180.801-92.664-68.339-48.361-93.447-57.257-49.178-38.751-28.563-26.615-23.679-21.22-20.737-21.018-20.32-27.142-14.621-11.317-10.665-13.671
Nettowinstmarge 000-12.5160000000000000000000
WPA (Winst Per Aandeel) -0.83-1.1-0.85-1.9-0.91-0.7-0.56-1.23-0.92-0.81-0.67-0.55-0.51-0.46-0.41-0.41-0.41-1.72-0.58-0.57-0.44-0.42-0.53
Verwaterde WPA -0.83-1.1-0.85-1.9-0.91-0.7-0.56-1.23-0.92-0.81-0.67-0.55-0.51-0.46-0.41-0.41-0.41-1.72-0.58-0.57-0.44-0.42-0.53
EBITDA -98.621-152.981-113.473-177.853-90.184-87.147-70.48-75.706-55.563-47.886-36.617-27.357-25.769-22.811-22.616-20.405-20.718-19.92-26.751-14.282-11.008-10.354-13.364
EBITDA ratio 000-8.2190000000000000000000